Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT03843125

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03843125. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

Study identification

NCT ID
NCT03843125
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,147 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2019 (Actual)
Primary completion
Apr 1, 2022 (Actual)
Completion
Apr 1, 2022 (Actual)
Last update posted
May 16, 2023

2019 – 2022

United States locations

U.S. sites
61
U.S. states
23
U.S. cities
54
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Arizona Arthritis & Rheumatology Research Phoenix Arizona 85032 —
Arizona Arthritis & Rheumatology Associates, P. C. Tucson Arizona 85704 —
Wallace Rheumatic Studies Center Beverly Hills California 90211 —
Medvin Clinical Research - Weidmann Covina California 91722 —
Providence Medical Foundation Fullerton California 92835 —
MD Medical Corporation Hemet California 92543 —
ACRC Studies Poway California 92064 —
Inland Rheumatology & Osteoporosis Medical Group Upland California 91786 —
Medvin Clinical Research - Weidmann Whittier California 90602 —
Denver Arthritis Clinic - Lowry Denver Colorado 80230 —
New England Research Associates Bridgeport Connecticut 06606 —
Arthritis and Rheumatic Disease Aventura Florida 33180 —
Clinical Research of West Florida, Inc. (Clearwater) Clearwater Florida 33765 —
Lakes Research, LLC Miami Lakes Florida 33014 —
Millennium Research Ormond Beach Florida 32174 —
Integral Rheumatology & Immunology Specialists Plantation Florida 33324 —
IRIS Research and Development, LLC Plantation Florida 33324 —
ForCare Clinical Research Tampa Florida 33613-1244 —
Tampa Medical Group, P.A. Tampa Florida 33614 —
Piedmont Healthcare Atlanta Georgia 30318 —
Emory University Atlanta Georgia 30322 —
North Georgia Rheumatology, PC Lawrenceville Georgia 30046 —
Arthritis Center of Lexington Lexington Kentucky 40504 —
Johns Hopkins Asthma and Allergy Center Baltimore Maryland 21224 —
Henry Ford Health System Detroit Michigan 48202 —
Advanced Rheumatology, PC Lansing Michigan 48910 —
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081 —
Glacir View Research Institute Kalispell Montana 59901 —
Allied Clinical Research Reno Nevada 89519 —
Arthritis and Osteoporosis Associates of New Mexico Las Cruces New Mexico 88011 —
St. Lawrence Health System Canton New York 13617 —
The Feinstein Institute for Medical Research Manhasset New York 11030 —
Columbia University Medical Center New York New York 10032 —
NYU Langone New York New York 11201 —
SUNY Upstate Medical University Syracuse New York 13210 —
Joint and Muscle Medical Care Charlotte North Carolina 28204 —
Box Arthritis & Rheumatology of the Carolinas, PLLC Charlotte North Carolina 28210 —
Medication Management Greensboro North Carolina 27408 —
Cincinnati Rheumatic Disease Study Group Cincinnati Ohio 45242 —
Paramount Medical Research Middleburg Heights Ohio 44130 —
Arthritis & Rheumatology Center of Oklahoma PLLC Oklahoma City Oklahoma 73102 —
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104-5046 —
East Penn Rheumatology Associates Bethlehem Pennsylvania 18015 —
Clinical Research Center of Reading,LLC Wyomissing Pennsylvania 19610 —
Articularis Healthcare d/b/a/ Low Country Rheumatology, PA Summerville South Carolina 29486 —
Eagle Medical Crossville Tennessee 38555 —
West Tennessee Research Institute Jackson Tennessee 38305 —
Amarillo Center for Clinical Research Amarillo Texas 79124 —
Accurate Clinical Management Baytown Texas 77521 —
Dr. Dhiman Basu Private Practice Colleyville Texas 76034 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Precision Comprehensive Clinical Research Solutions Fort Worth Texas 76107 —
Rheumatology Center Of Houston Houston Texas 77004 —
Accurate Clinical Research Houston Texas 77089 —
Southwest Rheumatology, P.A. Mesquite Texas 75150 —
Accurate Clinical Research, Inc. San Antonio Texas 78229 —
Advanced Rheumatology of Houston The Woodlands Texas 77382 —
Arthritis Clinic of Northern VA, P.C. Arlington Virginia 22205 —
Spectrum Medical Inc. Danville Virginia 24541 —
Rheumatic Disease Center Glendale Wisconsin 53217 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 236 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03843125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2023 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.